Overview

The Carbamazepine test measures the level of carbamazepine (Tegretol) in the blood to ensure therapeutic levels and avoid toxicity. Carbamazepine is an anticonvulsant used to treat epilepsy, bipolar disorder, and neuropathic pain.

Risk Assessment

• Toxicity Risk: Levels above the therapeutic range can cause dizziness, nausea, unsteady movements, blurred vision, confusion, or life-threatening conditions like seizures and heart arrhythmias.
• Subtherapeutic Risk: Levels below the therapeutic range may lead to ineffective seizure control or worsening of psychiatric symptoms.
• Drug Interactions: Carbamazepine interacts with many drugs, including phenytoin, valproic acid, and warfarin, which may alter its metabolism.
• Liver Function: The drug is metabolized in the liver, so patients with liver disease require close monitoring.

Normal Therapeutic Range:

• 4 – 12 mcg/mL (17 – 51 µmol/L).

Interpretation of Results

• Normal Therapeutic Range:

  • 4 – 12 mcg/mL (17 – 51 µmol/L)

• Toxic Levels:

  • Above 12 mcg/mL may indicate toxicity.
  • Severe toxicity symptoms typically appear above 15 mcg/mL.

• Subtherapeutic Levels:

  • Below 4 mcg/mL may indicate insufficient dosage.

• Other Considerations:

  • Autoinduction: Carbamazepine induces its own metabolism, meaning levels may drop after a few weeks, requiring dose adjustments.
  • Free vs. Total Drug: Some patients (e.g., those with low protein levels) may need free carbamazepine testing instead of total levels.

Sample Type

• Blood Sample (Serum or Plasma)
• Collected via venipuncture
• Typically drawn just before the next dose (trough level) to get the most accurate measurement.